1933 Industries Inc. (CSE:TGIF, FWB:1QF, OTC:VPGDF) is pleased to announce that its subsidiary, Spire Global Strategy (“Spire”), has been awarded a contract to develop a Cannabis Regulatory Compliance Course at Selkirk College, a post-secondary institution located in the epicentre of cannabis cultivation in the Province of British Columbia.

Due to its ideal climate, the Kootenay region is renowned for its outdoor and indoor cannabis cultivation which has been an economic driver in the area for over 40 years. Craft growers that have previously operated in the black or grey markets will now be able to learn how to become and remain compliant in the areas of micro-cultivating and processing within the new legal regime.


Spire offers a variety of advisory services to the burgeoning legal cannabis industry in Canada and abroad, and has utilized its experience in public policy development by assisting the Province of New Brunswick with the implementation of new adult-use cannabis legalization in that province. In addition, Spire provides strategic advice to private and public companies with regards to licensing applications, risk and resilience management, investigative due diligence, and compliance.

Andrew Richards, CEO of Spire remarked, “We are pleased to have been selected to develop and deliver the compliance course due to our deep subject matter expertise in this sector. We look forward to working with Selkirk College and engaging with craft growers in the region.”

About Selkirk College

Located amidst the breathtaking beauty of southern British Columbia, Selkirk College is home to 60-plus nationally recognized programs serving about 2,800 full-time learners per year in certificate, diploma, bachelor degree, co-operative education, and continuing education programs. With eight campus locations in six different West Kootenay and Boundary communities, Selkirk College offers outcomes for in-demand employment, credit transfer to a multitude of universities for degree completion, and enhanced training to further career opportunities.

About 1933 Industries Inc.

1933 Industries Inc. is a vertically integrated cannabis company with operations in the United States and Canada. Operating through three subsidiary companies, 1933 Industries owns licensed medical and adult-use cannabis cultivation and production assets, proprietary hemp-based, CBD infused products, CBD extraction services and a specialized cannabis advisory firm supporting clients in security, intelligence and due diligence.

Please visit our new website at www.1933industries.com

Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.

Notice regarding Forward Looking Statements: This news release contains forward-looking statements. The use of any of the words “anticipate”, “continue”, “estimate”, “expect”, “may”, “will”, “project”, “should”, “believe” and similar expressions are intended to identify forward-looking statements. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct.  Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this news release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company’s disclosure documents, which can be found under the Company’s profile on www.sedar.com.   1933 Industries undertakes no obligation to update publicly or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by law.

Click here to connect with 1933 Industries Inc. (CSE:TGIF, FWB:1QF, OTC:VPGDF)  for an Investor Presentation. 

Source: www.prnewswire.com

 Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) (“Lobe” or the “Company”) announces that Philip Young, CEO and Director, and Maghsoud Dariani, Chief Science Officer will be presenting on Thursday, February 25th, 2021 at 5:45 pm EST at “The Gold Standard in Psychedelic Investment, Psychedelic Capital Virtual Investment Conference”, a platform showcasing the top companies, latest IPOs, newest opportunities, and deepest industry insights.

As a presenting sponsor, the Company will connect directly with some of the earliest moving investors in the psychedelic industry and reach an audience of 2,000+ investors. Presentations are 30 minutes in length, with 10 minutes allocated to a one-on-one Q&A session with the audience.

Keep reading... Show less

As Canadian operators race to strengthen their positions in the cannabis landscape, are international pursuits outside North America still top of mind?

The role that mergers and acquisitions (M&A) have played in the expansion of Canadian companies across the globe has been monumental for the growth of the cannabis industry. Now the space has reached a critical point as the demands of the US market increase.

Keep reading... Show less

It’s been just over a year since recreational cannabis was legalised in the Australian Capital Territory (ACT), home to the nation’s capital city of Canberra.

Announced on September 25, 2019, and brought into effect on January 31, 2020, the rules make it legal to possess and personally use small amounts of cannabis.

Keep reading... Show less

Pac Roots Cannabis Corp. (CSE: PACR) (“PacRoots” or the “Company”), announces the closing of its previously announced non-brokered private placement (see press release dated January 25, 2021).

Aggregate gross proceeds of $1,340,685.90 were raised through the issuance of 7,448,255 units (each a “Unit”). Each Unit consists of one common shares and one share purchase warrant. Each warrant is exercisable at a price of $0.30 per share until February 23, 2024.

Keep reading... Show less

 Trulieve Cannabis Corp. (“Trulieve” or the “Company”) (CSE: TRUL) (OTC: TCNNF), a leading and top-performing cannabis company in the United States will release its fourth quarter 2020 financial results on Tuesday, March 23, 2021 before markets open. Following the earnings release, management will host a conference call at 8:30 AM Eastern Time to review the financial results.

All interested parties can join the conference call by dialing 1-888-231-8191 or 1-647-427-7450, conference ID: 7066881. Please dial in 15 minutes prior to the call to secure a line. The conference call will be archived for replay until March 30, 2021 . To access the archived conference call, please dial 1-855-859-2056 and enter the encore code 7066881.

Keep reading... Show less